CRL
Charles River Laboratories International, Inc. · Healthcare
EVP, Corp Strategy, Develop Joseph W Laplume sold $1.6M of Charles River Laboratories International, Inc.
Sold$1,583,522
$173.48Price
9,128Shares
−27%Stake
What CRL did after the filing
- The stock from Mon, Nov 13 close, $170.03
- +40.5%
- S&P 500, same days
- +8.7%
Measured over 30 trading days, to the Dec 27 close.
Traded Thu, Nov 9. Filed Mon, Nov 13, 11:12 AM ET, during the session. Returns use the Nov 13 close and the Dec 27 close. Not investment advice.